Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001567619-21-005402

Options or other derivatives

  • EVP, Chief Development Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Peterson Amy C. · EVP, Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-26 Grant or award : show line 1 in the form Stock Option (right to buy) +250,000 250,000 D
Loading xslF345X03/doc1.xml…